These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14713089)

  • 1. Model of metastatic growth valuable for radionuclide therapy.
    Bernhardt P; Ahlman H; Forssell-Aronsson E
    Med Phys; 2003 Dec; 30(12):3227-32. PubMed ID: 14713089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences among Monte Carlo codes in the calculations of voxel S values for radionuclide targeted therapy and analysis of their impact on absorbed dose evaluations.
    Pacilio M; Lanconelli N; Lo MS; Betti M; Montani L; Torres AL; Coca PM
    Med Phys; 2009 May; 36(5):1543-52. PubMed ID: 19544770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-energy electron emitters for targeted radiotherapy of small tumours.
    Bernhardt P; Forssell-Aronsson E; Jacobsson L; Skarnemark G
    Acta Oncol; 2001; 40(5):602-8. PubMed ID: 11669332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling of metastatic cure after radionuclide therapy: influence of tumor distribution, cross-irradiation, and variable activity concentration.
    Bernhardt P; Ahlman H; Forssell-Aronsson E
    Med Phys; 2004 Sep; 31(9):2628-35. PubMed ID: 15487746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production.
    Uusijärvi H; Bernhardt P; Rösch F; Maecke HR; Forssell-Aronsson E
    J Nucl Med; 2006 May; 47(5):807-14. PubMed ID: 16644751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-factor calculations for mouse models using Monte-Carlo simulations.
    Bitar A; Lisbona A; Bardiès M
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):343-51. PubMed ID: 17538523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
    Konijnenberg MW; Bijster M; Krenning EP; De Jong M
    J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo.
    Michel RB; Andrews PM; Rosario AV; Goldenberg DM; Mattes MJ
    Nucl Med Biol; 2005 Apr; 32(3):269-78. PubMed ID: 15820762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of electron dose-point kernels in water generated by the Monte Carlo codes, PENELOPE, GEANT4, MCNPX, and ETRAN.
    Uusijärvi H; Chouin N; Bernhardt P; Ferrer L; Bardiès M; Forssell-Aronsson E
    Cancer Biother Radiopharm; 2009 Aug; 24(4):461-7. PubMed ID: 19694581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-based radiation dose correction for yttrium-90 microsphere treatment of liver tumors with central necrosis.
    Liu CS; Lin KH; Lee RC; Tseng HS; Wang LW; Huang PI; Chao LS; Chang CY; Yen SH; Tung CJ; Wang SJ; Oliver Wong CY; Liu RS
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):660-8. PubMed ID: 20932691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy.
    Hindié E; Zanotti-Fregonara P; Quinto MA; Morgat C; Champion C
    J Nucl Med; 2016 May; 57(5):759-64. PubMed ID: 26912441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculation of electron and isotopes dose point kernels with FLUKA Monte Carlo code for dosimetry in nuclear medicine therapy.
    Botta F; Mairani A; Battistoni G; Cremonesi M; Di Dia A; Fassò A; Ferrari A; Ferrari M; Paganelli G; Pedroli G; Valente M
    Med Phys; 2011 Jul; 38(7):3944-54. PubMed ID: 21858991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized cocktail of 90Y/177Lu for radionuclide therapy of neuroendocrine tumors of various sizes: a simulation study.
    Peer-Firozjaei M; Tajik-Mansoury MA; Geramifar P; Ghorbani R; Zarifi S; Miller C; Rahmim A
    Nucl Med Commun; 2022 Jun; 43(6):646-655. PubMed ID: 35256576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
    Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
    J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry in Radiosynoviorthesis: 90Y VS. 153Sm.
    Torres Berdeguez MB; Thomas S; Medeiros S; de Sá LV; Mas Milian F; da Silva AX
    Health Phys; 2018 Jan; 114(1):1-6. PubMed ID: 28990969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma.
    Lee IJ; Seong J; Koom WS; Kim YB; Jeon BC; Kim JH; Han KH
    Jpn J Clin Oncol; 2011 Jul; 41(7):882-9. PubMed ID: 21515609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres.
    Chiesa C; Mira M; Maccauro M; Romito R; Spreafico C; Sposito C; Bhoori S; Morosi C; Pellizzari S; Negri A; Civelli E; Lanocita R; Camerini T; Bampo C; Carrara M; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):503-8. PubMed ID: 23358402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic schemes in 177Lu and 90Y-PRRT: radiobiological considerations.
    Sarnelli A; Guerriero F; Botta F; Ferrari M; Strigari L; Bodei L; D'Errico V; Grassi E; Fioroni F; Paganelli G; Orecchia R; Cremonesi M
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):216-231. PubMed ID: 26576734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.